Overview
Status
Active
Registry date
2025-07-02
Share capital
50,000.00 PLN
Registered address
ul. Jana Ciszewskiego 15, 02-777 Warszawa, Poland
Electronic delivery address
AE:PL-58154-41218-RHCHE-19
Financials
Filing timeliness
The financial statement for 2025 was filed on time.
- 202518/06/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 0.40MedianUSD 284.01kAverageUSD 6.97m
Net profit
This companyUSD -3.25kMedianUSD 4.93kAverageUSD 683.78k
Operating costs
This companyUSD 3.25kMedianUSD 387.31kAverageUSD 6.05m
Assets
This companyUSD 11.05kMedianUSD 349.52kAverageUSD 6.87m
Industry
Authorized Representatives
Adam Kiciak age 50 – Management Board Member
Karolina Aleksandra Chodkowska age 44 – Management Board Member
Mariusz Radosław Cięciara age 47 – Management Board Member
Manner of representation
Two members of the management board acting jointly are authorized to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 25 | $3,376.55 | 25% | |
| 75 | $10,129.66 | 75% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
AVES Labs sp. z o.o. | 6,753.11 USD | 50% |
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ALG Pharma sp. z o.o. | $16,237,368.88 | algpharma.pl | ||
| Yango sp. z o.o. | $8,214,312.60 | yango.pl | ||
| Iodica World sp. z o.o. | $1,668,750.20 | iodica.pl | ||
| Instytut Urządzeń Ekstrakcyjnych sp. z o.o. | $243,885.18 | sfe.com.pl | ||
| Moodary sp. z o.o. | $34,640.14 | ladujemy.pl | ||
| TRZY Wymiary sp. z o.o. | $3,985.66 | agencja3.pl | ||
| Polimer P.S.A. | $0.00 | polimer.pl | ||
| LL Supplements sp. z o.o. | – | tru.com.pl | ||
| Neotab sp. z o.o. | – | neotab.pl | ||
| Synteris Labs sp. z o.o. | – | synterislabs.pl |
FAQ
The main business activity of Vetera Labs focuses on manufacture of food supplements.
The company was registered in the Polish National Court Register (KRS) on July 2, 2025.
The headquarters is located at: ul. Jana Ciszewskiego 15, 02-777 Warszawa.
The management board includes: Adam Kiciak (Member of the Management Board) and Mariusz Radosław Cięciara (Member of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from July 2, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $0.
No, in 2025 the company reported a net loss of $3,247.
The largest operating cost category falls under external services. This category amounted to $2,927 in 2025, representing 90% of all operating expenses.
Last updated: 2026-06-19
